Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag symbols : PFE save search
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.225 -9.93% -11.02% 3.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | News | $17.565 3.63% 3.5% 940K
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $4.265 -2.63% -2.7% 1.7M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: -0.91%
H: 3.88%
C: 3.88%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -2.6%
H: 2.26%
C: 1.44%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -2.46%
H: 0.0%
C: 0.0%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: 4.66%
H: 0.0%
C: -3.92%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.04%
H: 0.11%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.37%
H: 0.21%
C: 0.05%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -1.28%
H: 1.05%
C: -0.72%
research global market
Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: -1.38%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.07%
H: 0.83%
C: 0.7%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.55%
H: 0.79%
C: 0.25%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 1.27%
H: 1.87%
C: 1.73%
EMN | $96.8 -0.27% 0.0% 520K
|
Process Industries
|
| O: 0.79%
H: 0.8%
C: 0.77%
drug expansion global growing
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.5 -1.32% -1.33% 1.7M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published: 2023-12-08 (Crawled : 16:00) - biospace.com/
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
kisqali breast risk novartis
Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -20.0%
H: 0.0%
C: 0.0%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PPCB | $0.0011 -41.86% 5.6M
|
Manufacturing
|
| O: 0.0%
H: 2.61%
C: -4.35%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
active market
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published: 2023-12-08 (Crawled : 14:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.07%
H: 1.1%
C: 0.45%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
kisqali breast risk novartis
Global Synthetic Hormones Market Analysis and Forecast, 2023-2033: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape
Published: 2023-11-25 (Crawled : 00:20) - prnewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
global market
Global Vaginitis Therapeutics Market Size Projected to Reach USD 7.20 Billion By 2032, With 8.1% CAGR Growth: Polaris Market Research
Published: 2023-11-23 (Crawled : 15:30) - prnewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
reach research global therapeutics market
Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published: 2023-10-30 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -4.67%
H: 4.9%
C: 4.9%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.43%
H: 1.46%
C: 1.03%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.69%
H: 0.25%
C: -0.07%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.39%
H: 0.79%
C: 0.64%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 2.29%
H: 0.44%
C: -0.23%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
research therapeutics study market
Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Published: 2023-10-20 (Crawled : 10:00) - globenewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.42%
H: 0.16%
C: -1.32%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.6%
H: 0.61%
C: -0.56%
kisqali breast cancer risk novartis
Dyadic Appoints Doug Pace to Its Executive Leadership Team
Published: 2023-10-09 (Crawled : 13:00) - globenewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.21%
H: 1.24%
C: 0.42%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.01%
H: 0.47%
C: 0.45%
DYAI 4 | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: -2.45%
H: 0.0%
C: -2.01%
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: 3.0%
H: 0.0%
C: -3.43%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.26%
H: 1.04%
C: 0.03%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.51%
H: 0.26%
C: -0.72%
SRPT | $117.065 0.09% 0.09% 440K
|
Health Technology
|
| O: -0.27%
H: 0.54%
C: -0.84%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 0.16%
H: 2.0%
C: 1.42%
IONS | $41.85 1.9% 1.86% 630K
|
Health Technology
|
| O: -0.57%
H: 0.35%
C: -1.11%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: -0.82%
ARWR | $23.775 -0.61% -0.61% 830K
|
Health Technology
|
| O: 0.16%
H: 0.46%
C: -5.46%
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
|
| O: -0.74%
H: 2.42%
C: -3.47%
therapeutics market
Optic Nerves Disorder Treatment Market Rises: North America Takes the Helm
Published: 2023-09-14 (Crawled : 00:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 1.84%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.47%
H: 0.41%
C: -0.26%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.28%
H: 1.0%
C: 0.76%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 1.78%
H: 1.76%
C: 1.07%
america treatment market
Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights
Published: 2023-09-04 (Crawled : 16:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
ENDP | News | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
| Email alert
Add to watchlist
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
global market
North America Kidney Transplant Research Report 2023
Published: 2023-08-08 (Crawled : 22:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: 3.93%
H: 0.0%
C: -3.08%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.11%
H: 1.29%
C: 0.67%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
MDT | $81.29 0.89% 0.0% 5.2M
|
Health Technology
|
| O: -1.98%
H: 1.7%
C: 0.81%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: 0.0%
america report kidney research
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
NBIX | News M | $140.11 4.83% 4.6% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $128.725 -39.66% 750
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.95%
H: 0.19%
C: -0.32%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.19%
H: 0.11%
C: -1.46%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.01%
H: 0.16%
C: -0.32%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.03%
H: 0.12%
C: -0.24%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.91%
H: 0.56%
C: -0.5%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.15%
H: 1.18%
C: 0.43%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.06%
H: 0.46%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.21%
H: 0.42%
C: 0.13%
report business cancer treat global
Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published: 2023-06-15 (Crawled : 10:00) - prnewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.13%
H: 1.07%
C: 0.86%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.04%
H: 0.78%
C: 0.67%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.06%
H: 1.91%
C: 1.32%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.33%
H: 2.62%
C: 2.43%
market
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Published: 2023-06-02 (Crawled : 12:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.6%
H: 1.07%
C: 0.29%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.03%
H: 0.84%
C: 0.82%
kisqali breast risk novartis
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.